Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Billings, Ryan Taft

Premium

CollabRx has appointed Paul Billings to its board of directors.

Billings most recently served as chief medical officer at Life Technologies. He is executive chairman of Melanoma Diagnostics, a director of Trovagene, and a co-founder and past medical director of the Cordblood Registry. He was also a senior vice president for corporate development at Laboratory Corporation of America and a co-founder of Omicia.


Ryan Taft has joined Illumina as director of scientific research.

Taft is laboratory head and senior research fellow at the University of Queensland's Institute for Molecular Bioscience. He holds a BSc in biochemistry and molecular biology from the University of California, Davis. Taft will maintain a joint appointment with UQ while working for Illumina.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.